1. HOME
2. Research Insight
3. Key Players in the Human Identification Market are Focusing on Product Launches, Expansions, Agreements, and Partnerships

The human identification market is projected to reach USD 1,740.2 Million by 2022 from an estimated USD 928.0 Million in 2017, at a CAGR of 13.4%. The major factors driving the growth of this market are government initiatives for forensic programs and technological advancement.

The human identification market is consolidated in nature due to the presence of a large number of players. The key players are Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Promega Corporation (US), Agilent Technologies Inc. (US), General Electric Company (GE Healthcare) (US), Laboratory Corporation of America Holdings (US), Illumina, Inc. (US), LGC Limited (US), Eurofins Scientific (Luxembourg), NMS Labs Inc. (US), IntegenX Inc. (US), Hamilton Company (US), PerkinElmer, Inc. (US), Bio-Rad Laboratories, Inc. (US), Alere (US), Tecan Trading AG (Switzerland), Ciro Manufacturing Corporation (US), Key Forensic Services Limited (UK), Sorenson Forensics (US), Parseq Lab s.r.o. (Czech Republic), DNA Diagnostics Center (US), PT&C Forensic Consulting Services P.A. (Envista Forensics) (UK), InnoGenomics Technologies, LLC. (US), Trinity DNA Solutions (US), and Genex Diagnostics, Inc. (US).

Expansions, partnerships, agreements, and product launches were the key strategies followed by players in the human identification market. Some of the leading players that adopted this strategy include Thermo Fisher Scientific Inc. (US), Promega Corporation (US), QIAGEN N.V. (Netherlands), Illumina Inc. (US), and Agilent Technologies Inc. (US).

The Thermo Fisher Scientific Inc. (US) is one of the key players in the human identification market. The company focuses on organic strategies and inorganic strategy to strengthen its position in the human identification market. For instance, in 2017, the company launched Precision ID GlobalFiler NGS STR Panel v2 and QuantStudio 5 Real-Time PCR System. In 2015, Thermo Fisher Scientific established the Customer Experience Center (CEC) in Dubai. In 2014, the company acquired Life Technologies (US) for approximately USD 13.6 billion. The acquisition increased the company’s presence and market share in the global human identification market. Also, in 2016, the company partnered with Hamilton Bonaduz AG (Germany) to provide products to forensic customers.

 QIAGEN N.V. (Netherlands) is another major player in this market. The company focuses on inorganic and organic strategies to maintain and enhance its position in the market. For instance, in 2017, the company collaborated with 10x Genomics (US) to develop and promote comprehensive solutions for next-generation sequencing (NGS). Furthermore, in November 2016, the company relaunched the GeneReader NGS System in the US.

Promega Corporation (US) accounted for the third-largest share of the human identification market in 2016. Promega Corporation has a broad array of products related to human identification such as STR analysis, human specific quantification systems and assays & kits. The company focuses on organic growth strategies such as product launches. In January 2015, the company launched the Promega PowerPlex Fusion 6C System.

Related Reports:

Human Identification Market by Product & Services (Consumables, Instruments, Software), Technology (PCR, Capillary Electrophoresis, NGS, Microarray), Application (Forensic, Paternity Testing), End User (Forensic Laboratories) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: [email protected]